Horizon Pharma plc to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference

Horizon Pharma plc to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference

09/04/18

DUBLIN--(BUSINESS WIRE)--Sep. 4, 2018-- Horizon Pharma plc (Nasdaq: HZNP) announced today that the company will participate in the following conference:

Morgan Stanley 16th Annual Global Healthcare Conference

  • Date: Sept. 13, 2018
  • Presentation Time: 10:35 a.m. ET
  • Location: New York, NY

The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.

About Horizon Pharma plc

Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com, follow us @HZNPplc on Twitter or like us on Facebook.

Source: Horizon Pharma plc

Horizon Pharma
Investors:
Tina Ventura
Senior Vice President,
Investor Relations
investor-relations@horizonpharma.com
or
Ruth Venning
Executive Director,
Investor Relations
investor-relations@horizonpharma.com
or
U.S. Media:
Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief Communications Officer
media@horizonpharma.com
or
Ireland Media:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie